VKTX logo

Viking Therapeutics (VKTX) Retained earnings

annual retained earnings:

-$487.91M-$109.96M(-29.10%)
December 31, 2024

Summary

  • As of today (May 29, 2025), VKTX annual retained earnings is -$487.91 million, with the most recent change of -$109.96 million (-29.10%) on December 31, 2024.
  • During the last 3 years, VKTX annual retained earnings has fallen by -$264.73 million (-118.61%).
  • VKTX annual retained earnings is now -439455.86% below its all-time high of -$111.00 thousand, reached on December 31, 2012.

Performance

VKTX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXbalance sheet metrics

quarterly retained earnings:

-$533.54M-$45.63M(-9.35%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VKTX quarterly retained earnings is -$533.54 million, with the most recent change of -$45.63 million (-9.35%) on March 31, 2025.
  • Over the past year, VKTX quarterly retained earnings has dropped by -$128.24 million (-31.64%).
  • VKTX quarterly retained earnings is now -109635.91% below its all-time high of -$486.20 thousand, reached on March 31, 2014.

Performance

VKTX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

VKTX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-29.1%-31.6%
3 y3 years-118.6%-123.0%
5 y5 years-279.1%-285.6%

VKTX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-118.6%at low-123.0%at low
5 y5-year-279.1%at low-285.6%at low
alltimeall time<-9999.0%at low<-9999.0%at low

VKTX Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$533.54M(+9.4%)
Dec 2024
-$487.91M(+29.1%)
-$487.91M(+7.8%)
Sep 2024
-
-$452.49M(+5.8%)
Jun 2024
-
-$427.55M(+5.5%)
Mar 2024
-
-$405.30M(+7.2%)
Dec 2023
-$377.94M(+29.4%)
-$377.94M(+7.0%)
Sep 2023
-
-$353.34M(+6.8%)
Jun 2023
-
-$330.81M(+6.2%)
Mar 2023
-
-$311.58M(+6.7%)
Dec 2022
-$292.05M(+30.9%)
-$292.05M(+7.2%)
Sep 2022
-
-$272.49M(+6.1%)
Jun 2022
-
-$256.72M(+7.3%)
Mar 2022
-
-$239.28M(+7.2%)
Dec 2021
-$223.18M(+32.7%)
-$223.18M(+5.9%)
Sep 2021
-
-$210.83M(+6.7%)
Jun 2021
-
-$197.58M(+8.4%)
Mar 2021
-
-$182.20M(+8.3%)
Dec 2020
-$168.19M(+30.7%)
-$168.19M(+7.0%)
Sep 2020
-
-$157.24M(+6.3%)
Jun 2020
-
-$147.96M(+6.9%)
Mar 2020
-
-$138.38M(+7.5%)
Dec 2019
-$128.70M
-$128.70M(+6.1%)
Sep 2019
-
-$121.25M(+5.0%)
DateAnnualQuarterly
Jun 2019
-
-$115.52M(+7.1%)
Mar 2019
-
-$107.84M(+4.8%)
Dec 2018
-$102.92M(+27.3%)
-$102.92M(+5.4%)
Sep 2018
-
-$97.68M(+7.2%)
Jun 2018
-
-$91.08M(+7.9%)
Mar 2018
-
-$84.41M(+4.4%)
Dec 2017
-$80.86M(+34.1%)
-$80.86M(+5.3%)
Sep 2017
-
-$76.77M(+8.6%)
Jun 2017
-
-$70.67M(+7.9%)
Mar 2017
-
-$65.50M(+8.7%)
Dec 2016
-$60.28M(+32.3%)
-$60.28M(+6.4%)
Sep 2016
-
-$56.63M(+7.2%)
Jun 2016
-
-$52.83M(+7.5%)
Mar 2016
-
-$49.13M(+7.9%)
Dec 2015
-$45.55M(+105.7%)
-$45.55M(+12.6%)
Sep 2015
-
-$40.45M(+13.3%)
Jun 2015
-
-$35.72M(+28.2%)
Mar 2015
-
-$27.85M(+25.8%)
Dec 2014
-$22.14M(+8505.3%)
-$22.14M(-4.8%)
Jun 2014
-
-$23.27M(+4685.9%)
Mar 2014
-
-$486.20K
Dec 2013
-$257.30K(+131.8%)
-
Dec 2012
-$111.00K
-

FAQ

  • What is Viking Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Viking Therapeutics?
  • What is Viking Therapeutics annual retained earnings year-on-year change?
  • What is Viking Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Viking Therapeutics?
  • What is Viking Therapeutics quarterly retained earnings year-on-year change?

What is Viking Therapeutics annual retained earnings?

The current annual retained earnings of VKTX is -$487.91M

What is the all time high annual retained earnings for Viking Therapeutics?

Viking Therapeutics all-time high annual retained earnings is -$111.00K

What is Viking Therapeutics annual retained earnings year-on-year change?

Over the past year, VKTX annual retained earnings has changed by -$109.96M (-29.10%)

What is Viking Therapeutics quarterly retained earnings?

The current quarterly retained earnings of VKTX is -$533.54M

What is the all time high quarterly retained earnings for Viking Therapeutics?

Viking Therapeutics all-time high quarterly retained earnings is -$486.20K

What is Viking Therapeutics quarterly retained earnings year-on-year change?

Over the past year, VKTX quarterly retained earnings has changed by -$128.24M (-31.64%)
On this page